Lightrock Netherlands’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.4M Sell
207,151
-50,091
-19% -$4.26M 3.23% 11
2026
Q1
$22.2M Buy
257,242
+1,842
+0.7% +$165K 4.74% 4
2025
Q4
$22.3M Buy
255,400
+3,500
+1% +$266K 4.62% 5
2025
Q3
$12.3M Buy
251,900
+14,750
+6% +$849K 3.21% 13
2025
Q2
$11.9M Buy
237,150
+77,300
+48% +$4.99M 3.28% 7
2025
Q1
$11.7M Buy
159,850
+58,006
+57% +$4.79M 3.08% 11
2024
Q4
$8.47M Buy
+101,844
New +$8.03M 2.97% 15

Other funds holding GMED

Lightrock Netherlands's GMED Position: Q2 2026 in Review

Lightrock Netherlands reduced its Globus Medical (GMED) stake by 19% in Q2 2026, selling an estimated $4.26M and leaving 207,151 shares worth $16.4M. The position accounts for 3.23% of the portfolio, ranked #11.

Lightrock Netherlands first reported a position in GMED in Q4 2024 and has held it in 7 quarters since. The position peaked at $22.3M in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Lightrock Netherlands held 207,151 shares of Globus Medical worth $16.4M as of Q2 2026.
  • Lightrock Netherlands sold 50,091 Globus Medical shares in Q2 2026, an estimated $4.26M.
  • Globus Medical made up 3.23% of Lightrock Netherlands's portfolio in Q2 2026, its #11 holding.
  • Lightrock Netherlands first reported a position in Globus Medical in Q4 2024 and has held it in 7 quarters since.
  • Lightrock Netherlands's Globus Medical position peaked at $22.3M in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Lightrock Netherlands's 13F filing for Q2 2026, filed 10 Aug 2026.